These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 17149701)

  • 1. Breast cancer mortality after screening mammography in British Columbia women.
    Coldman A; Phillips N; Warren L; Kan L
    Int J Cancer; 2007 Mar; 120(5):1076-80. PubMed ID: 17149701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.
    Coldman AJ; Phillips N; Olivotto IA; Gordon P; Warren L; Kan L
    J Med Screen; 2008; 15(4):182-7. PubMed ID: 19106258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97.
    Olivotto IA; Kan L; d'Yachkova Y; Burhenne LJ; Hayes M; Hislop TG; Worth AJ; Basco VE; King S
    J Med Screen; 2000; 7(3):152-9. PubMed ID: 11126165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
    Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
    AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
    Tabar L; Yen MF; Vitak B; Chen HH; Smith RA; Duffy SW
    Lancet; 2003 Apr; 361(9367):1405-10. PubMed ID: 12727392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population studies of the effectiveness of mammographic screening.
    Coldman A; Phillips N
    Prev Med; 2011 Sep; 53(3):115-7. PubMed ID: 21798279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of nonbreast cancer incidence, survival and mortality between breast screening program participants and nonparticipants.
    Phillips N; Coldman A
    Int J Cancer; 2008 Jan; 122(1):197-201. PubMed ID: 17721881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
    Olivotto IA; Kan L; Mates D; King S
    CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-Canadian study of mammography screening and mortality from breast cancer.
    Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.
    Njor S; Nyström L; Moss S; Paci E; Broeders M; Segnan N; Lynge E;
    J Med Screen; 2012; 19 Suppl 1():33-41. PubMed ID: 22972809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
    Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post screen-detected breast cancer within the Screening Mammography Program of British Columbia.
    Hislop TG; Worth AJ; Kan L; Rousseau E
    Breast Cancer Res Treat; 1997 Feb; 42(3):235-42. PubMed ID: 9065607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
    Weisstock CR; Rajapakshe R; Bitgood C; McAvoy S; Gordon PB; Coldman AJ; Parker BA; Wilson C
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1084-92. PubMed ID: 23963801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.